Literature DB >> 22430509

The chemokine receptor CXCR3 limits injury after acute toxic liver damage.

Mirko Moreno Zaldivar1, Marie-Luise Berres, Hacer Sahin, Andreas Nellen, Daniel Heinrichs, Petra Schmitz, Nicolaus Gassler, Konrad L Streetz, Christian Trautwein, Hermann E Wasmuth.   

Abstract

Although acute liver failure is a rare disease, its presence is associated with high morbidity and mortality in affected patients. While a contribution of the immune system to the outcome of toxic liver failure is anticipated, functionally relevant immune cell receptors for liver cell damage need to be better defined. We here investigate the relevance of the chemokine receptor CXCR3, which is important for hepatic immune cell infiltration, in a model of experimental acute liver failure. Liver injury was induced by a single intraperitoneal injection of carbon tetrachloride (CCl(4)) in CXCR3(-/-), CCR1(-/-), CCR5(-/-) and wild-type mice. In this model, CXCR3(-/-) mice displayed augmented liver damage compared with all other mouse strains as assessed by liver histology and serum transaminases 24 and 72 h after injury. Phenotypically, CXCR3(-/-) mice had significantly reduced intrahepatic NK and NKT cells after injury at all investigated time points (all P<0.05), but strongly elevated expression levels of IL1-β, TNF-α and IFN-γ. In line with a functional role of innate immune cells, wild-type mice depleted for NK cells with an anti-ASIALO GM1 antibody before liver injury also displayed increased liver injury after CCl(4) challenge. CXCR3(-/-) and NK cell-depleted mice show reduced apoptotic liver cells (TUNEL assay), but more necrotic hepatocytes. Functionally, the augmented liver cell necrosis in CXCR3(-/-) and NK cell-depleted mice was associated with increased expression of high mobility group 1 (HMGB1) protein and a consecutive enhanced infiltration of neutrophils into the liver. In conclusion, the results demonstrate a primarily unexpected beneficial role of CXCR3 in acute toxic liver injury. These findings should be taken into account when planning trials with CXCR3 antagonists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22430509     DOI: 10.1038/labinvest.2012.48

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

Review 1.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

2.  The role of chemokines in acute liver injury.

Authors:  Yedidya Saiman; Scott L Friedman
Journal:  Front Physiol       Date:  2012-06-20       Impact factor: 4.566

3.  Anti-asialo GM1 NK cell depleting antibody does not alter the development of bleomycin induced pulmonary fibrosis.

Authors:  Justin Monnier; Brian A Zabel
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

4.  Key features and homing properties of NK cells in the liver are shaped by activated iNKT cells.

Authors:  Stephanie Trittel; Benedict J Chambers; Ulrike Heise; Carlos A Guzmán; Peggy Riese
Journal:  Sci Rep       Date:  2019-11-08       Impact factor: 4.379

5.  Gadolinium Chloride Inhibits the Production of Liver Interleukin-27 and Mitigates Liver Injury in the CLP Mouse Model.

Authors:  Jing Fan; Miao He; Chuan-Jiang Wang; Mu Zhang
Journal:  Mediators Inflamm       Date:  2021-01-29       Impact factor: 4.711

Review 6.  The role of chemokines in hepatitis C virus-mediated liver disease.

Authors:  Anette Brass; Erwin Daniel Brenndörfer
Journal:  Int J Mol Sci       Date:  2014-03-18       Impact factor: 5.923

7.  Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseases.

Authors:  Morgan K Groover; Jillian M Richmond
Journal:  F1000Res       Date:  2020-10-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.